Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05921994

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

Sponsor: Novartis Pharmaceuticals

View on ClinicalTrials.gov

Summary

The purpose of this observational, prospective, non-interventional, multicenter, open-label, single arm study in Hidradenitis suppurativa (HS) is to assess the treatment pattern of secukinumab in a flexible dosing regimen and decision influencing factors for flexible dosing in a real-world population over 2 years.

Official title: Long Term observAtional, Prospective, Multicenter Study to Collect iN a Real-world populatIon Data on the treatMent Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (ANIMA)

Key Details

Gender

All

Age Range

18 Years - 99 Years

Study Type

OBSERVATIONAL

Enrollment

424

Start Date

2023-08-10

Completion Date

2027-03-31

Last Updated

2026-02-23

Healthy Volunteers

No

Interventions

OTHER

secukinumab

Prospective observational study. There is no treatment allocation. Patients administered secukinumab by prescription and administered according to the SmPC.

Locations (80)

Novartis Investigative Site

Freiburg im Breisgau, Baden-Wurttemberg, Germany

Novartis Investigative Site

Rheinstetten, Baden-Wurttemberg, Germany

Novartis Investigative Site

Haßfurt, Bavaria, Germany

Novartis Investigative Site

Kulmbach, Bavaria, Germany

Novartis Investigative Site

Lauf an der Pegnitz, Bavaria, Germany

Novartis Investigative Site

Nuremberg, Bavaria, Germany

Novartis Investigative Site

Panketal, Brandenburg, Germany

Novartis Investigative Site

Hamburg, Hamburg, Germany

Novartis Investigative Site

Lingen Ems, Lower Saxony, Germany

Novartis Investigative Site

Bergen auf Rügen, Mecklenburg-Vorpommern, Germany

Novartis Investigative Site

Kröpelin, Mecklenburg-Vorpommern, Germany

Novartis Investigative Site

Krefeld, North Rhine-Westphalia, Germany

Novartis Investigative Site

Mainz, Rhineland-Palatinate, Germany

Novartis Investigative Site

Dresden, Saxony, Germany

Novartis Investigative Site

Leipzig, Saxony, Germany

Novartis Investigative Site

Leipzig, Saxony, Germany

Novartis Investigative Site

Wittenberg, Saxony-Anhalt, Germany

Novartis Investigative Site

Aachen, Germany

Novartis Investigative Site

Ahaus, Germany

Novartis Investigative Site

Annaberg-Buchholz, Germany

Novartis Investigative Site

Bad Steben, Germany

Novartis Investigative Site

Baden-Baden, Germany

Novartis Investigative Site

Berlin, Germany

Novartis Investigative Site

Berlin, Germany

Novartis Investigative Site

Bielefeld, Germany

Novartis Investigative Site

Bochum, Germany

Novartis Investigative Site

Bonn, Germany

Novartis Investigative Site

Brandenburg, Germany

Novartis Investigative Site

Bremen, Germany

Novartis Investigative Site

Buxtehude, Germany

Novartis Investigative Site

Bückeburg, Germany

Novartis Investigative Site

Chemnitz, Germany

Novartis Investigative Site

Chemnitz, Germany

Novartis Investigative Site

Cologne, Germany

Novartis Investigative Site

Delitzsch, Germany

Novartis Investigative Site

Dessau, Germany

Novartis Investigative Site

Dorsten, Germany

Novartis Investigative Site

Dortmund, Germany

Novartis Investigative Site

Dresden, Germany

Novartis Investigative Site

Düren, Germany

Novartis Investigative Site

Emsdetten, Germany

Novartis Investigative Site

Erlangen, Germany

Novartis Investigative Site

Falkenberg, Germany

Novartis Investigative Site

Falkensee, Germany

Novartis Investigative Site

Freising, Germany

Novartis Investigative Site

Geilenkirchen, Germany

Novartis Investigative Site

Gera, Germany

Novartis Investigative Site

Gernsbach, Germany

Novartis Investigative Site

Gladbeck, Germany

Novartis Investigative Site

Großenhain, Germany

Novartis Investigative Site

Hamburg, Germany

Novartis Investigative Site

Hamburg, Germany

Novartis Investigative Site

Hanover, Germany

Novartis Investigative Site

Haslach im Kinzigtal, Germany

Novartis Investigative Site

Hofgeismar, Germany

Novartis Investigative Site

Jena, Germany

Novartis Investigative Site

Jülich, Germany

Novartis Investigative Site

Karlsruhe, Germany

Novartis Investigative Site

Kempen, Germany

Novartis Investigative Site

Lübeck, Germany

Novartis Investigative Site

Magdeburg, Germany

Novartis Investigative Site

Magdeburg, Germany

Novartis Investigative Site

Mainz, Germany

Novartis Investigative Site

Marburg, Germany

Novartis Investigative Site

Minden, Germany

Novartis Investigative Site

Mönchengladbach, Germany

Novartis Investigative Site

Neu Wulmstorf, Germany

Novartis Investigative Site

Nuremberg, Germany

Novartis Investigative Site

Oberasbach, Germany

Novartis Investigative Site

Oelde, Germany

Novartis Investigative Site

Peitz, Germany

Novartis Investigative Site

Potsdam, Germany

Novartis Investigative Site

Remscheid, Germany

Novartis Investigative Site

Selters, Germany

Novartis Investigative Site

Simmern, Germany

Novartis Investigative Site

Soest, Germany

Novartis Investigative Site

Stolberg, Germany

Novartis Investigative Site

Unna, Germany

Novartis Investigative Site

Wittlich, Germany

Novartis Investigative Site

Wuppertal, Germany